Beth Israel Deaconess — Boston, Massachusetts

Beth Israel Deaconess is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess has participated in 23 clinical trials with 7 currently active.

Therapeutic areas: Relapsed Refractory Multiple Myeloma, Critical Limb Ischemia, Stroke.

Sponsors: Multiple Myeloma Research Consortium, Harvest Technologies, Yale University.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess?

Beth Israel Deaconess has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess conducted?

Beth Israel Deaconess has 23 clinical trials on record, with 7 currently active. Their work covers Relapsed Refractory Multiple Myeloma, Critical Limb Ischemia, Stroke.

Is Beth Israel Deaconess accredited by Crixeo Health?

Yes — Beth Israel Deaconess holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Beth Israel Deaconess?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.